Barrett Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$474K Sell
1,656
-1,019
-38% -$262K 0.02% 146
2021
Q4
$739K Buy
2,675
+1,200
+81% +$304K 0.03% 134
2021
Q3
$341K Sell
1,475
-1,600
-52% -$395K 0.02% 155
2021
Q2
$706K Hold
3,075
0.03% 120
2021
Q1
$574K Buy
3,075
+1,475
+92% +$289K 0.03% 125
2020
Q4
$270K Hold
1,600
0.01% 155
2020
Q3
$237K Hold
1,600
0.01% 154
2020
Q2
$263K Buy
+1,600
New +$246K 0.02% 137
2018
Q4
Sell
-112
Closed -$12K 374
2018
Q3
$12K Hold
112
﹤0.01% 322
2018
Q2
$10K Hold
112
﹤0.01% 335
2018
Q1
$9K Hold
112
﹤0.01% 342
2017
Q4
$9K Hold
112
﹤0.01% 348
2017
Q3
$10K Hold
112
﹤0.01% 325
2017
Q2
$9K Hold
112
﹤0.01% 335
2017
Q1
$9K Buy
+112
New +$8.97K ﹤0.01% 321
2013
Q4
Sell
-80
Closed -$4K 336
2013
Q3
$4K Buy
+80
New +$4.19K ﹤0.01% 325

Other funds holding LLY

Barrett Asset Management's LLY Position: Q1 2022 in Review

Barrett Asset Management reduced its Eli Lilly (LLY) stake by 38% in Q1 2022, selling an estimated $262K and leaving 1,656 shares worth $474K. The position accounts for 0.02% of the portfolio, ranked #146.

Barrett Asset Management first reported a position in LLY in Q3 2013 and has held it in 16 quarters since. The position peaked at $739K in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Barrett Asset Management held 1,656 shares of Eli Lilly worth $474K as of Q1 2022.
  • Barrett Asset Management sold 1,019 Eli Lilly shares in Q1 2022, an estimated $262K.
  • Eli Lilly made up 0.02% of Barrett Asset Management's portfolio in Q1 2022, its #146 holding.
  • Barrett Asset Management first reported a position in Eli Lilly in Q3 2013 and has held it in 16 quarters since.
  • Barrett Asset Management's Eli Lilly position peaked at $739K in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.